phenyl acetate has been researched along with Agitation, Psychomotor in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, PB; Gabbita, P; Moorthy, G; Sallans, L; Sallee, F; Zemlan, F | 1 |
| Gordon, SM; Regan, WM | 1 |
| Basavaraju, N; Goldenberg, G; Kahaner, K; Rangu, S | 1 |
| Brandes, M; Low, RA | 1 |
| Herrmann, N; Lanctôt, K; Myszak, M | 1 |
| Feinberg, TE; Meckler, L; Miner, CR; Roane, DM; Rosenthal, RN; Scicutella, A | 1 |
| Bascialla, F; Bozikas, V; Karavatos, A; Savvidou, I; Yulis, P | 1 |
| Devitt, PJ; Dewan, MJ; Megna, JL; Sauro, MD | 1 |
3 trial(s) available for phenyl acetate and Agitation, Psychomotor
| Article | Year |
|---|---|
Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD.
Topics: Acetates; Administration, Oral; Adult; Attention Deficit Disorder with Hyperactivity; Betahistine; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Psychomotor Agitation; Pyridines; Single-Blind Method; Young Adult | 2015 |
Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Anti-Anxiety Agents; Behavioral Symptoms; Cyclohexanecarboxylic Acids; Dementia; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Prospective Studies; Psychomotor Agitation | 2000 |
Gabapentin's effect on agitation in severely and persistently mentally ill patients.
Topics: Acetates; Amines; Antimanic Agents; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Mental Disorders; Middle Aged; Mood Disorders; Pilot Projects; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Retrospective Studies; Time Factors | 2002 |
5 other study(ies) available for phenyl acetate and Agitation, Psychomotor
| Article | Year |
|---|---|
Gabapentin for behavioral agitation in Alzheimer's disease.
Topics: Acetates; Aged; Alzheimer Disease; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Psychomotor Agitation; Treatment Outcome | 1997 |
Gabapentin for disruptive behaviour in an elderly demented patient.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Dementia; Dose-Response Relationship, Drug; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; New York; Nursing Homes; Psychomotor Agitation | 1998 |
Gabapentin for the management of agitation.
Topics: Acetates; Aggression; Amines; Cyclohexanecarboxylic Acids; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Psychomotor Agitation | 1999 |
Treatment of dementia-associated agitation with gabapentin.
Topics: Acetates; Aged; Aged, 80 and over; Alzheimer Disease; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Dementia, Multi-Infarct; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Mental Status Schedule; Neurologic Examination; Psychomotor Agitation | 2000 |
Gabapentin for behavioral dyscontrol with mental retardation.
Topics: Acetates; Adult; Amines; Anticonvulsants; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Intellectual Disability; Mental Disorders; Psychomotor Agitation; Treatment Outcome | 2001 |